Latest Security News

Platinum Capital Limited has withdrawn its proposed scheme of arrangement due to insufficient shareholder support and is now seeking approval for an on-market buy-back of up to 50% of its shares, aiming to enhance liquidity for investors.

Anteris Technologies reported solid clinical progress with 130 patients implanted with its DurAVR heart valve and is gearing up for its pivotal PARADIGM trial with 79 qualified sites worldwide. The company also strengthened its leadership with two new board members amid ongoing FDA engagement.

LGI Limited reported a 14% rise in FY25 EBITDA to $17.4 million, driven by operational growth and expanded renewable capacity. The company also secured a landmark 15-year contract to build and operate a 12MW/24MWh battery system at the Belrose landfill site in NSW.

Forrestania Resources has secured gold rights over key tenements adjacent to its Ada Ann project, enhancing its exploration potential in Western Australia’s Bonnie Vale region.

Tesoro Gold has successfully dismissed initial legal claims from joint venture partner Wanaco SpA and increased its ownership in the El Zorro Gold Project to over 90%, reinforcing its strategic position in Chile.

LGI Limited reported a robust FY25 with a 13.6% increase in underlying EBITDA to $17.4 million, expanded renewable capacity by 44%, and declared a fully franked dividend. The company’s strategic investments in battery storage and biogas infrastructure position it well in Australia’s energy transition.

Anteris Technologies Global Corp. reported a $42.7 million net loss for the first half of 2025 amid advancing preparations for its pivotal DurAVR Transcatheter Heart Valve trial. The company’s recent IPO proceeds are fueling R&D and manufacturing scale-up as it targets regulatory approvals.

Archer Materials has partnered with Belgium’s IMEC to develop a scalable, cost-effective potassium ion biosensor using silicon semiconductor technology, aiming to accelerate commercial production by late 2025.

Everest Metals Corporation has raised $4 million through a share placement to advance its gold and critical minerals projects in Western Australia, including pioneering rubidium extraction technology.

Tryptamine Therapeutics has locked in $2.6 million in non-dilutive funding to fast-track clinical trials of its lead psilocin-based therapy, TRP-8803, targeting binge eating disorder and other conditions.

oOh!media has appointed James Taylor, current SBS Managing Director, as its new CEO, set to take the helm in early 2026. This leadership change signals a strategic push for growth in Australia's fast-evolving out-of-home media sector.

Iondrive Limited has won a $3.9 million government grant to advance its innovative urban mining technology, accelerating the construction of a pilot plant focused on critical minerals recovery from lithium-ion batteries.